Conatus Pharmaceuticals Inc. buy Quitte
Start price
24.08.18
/
50%
€46.45
Target price
06.12.18
€58.63
Performance (%)
-60.00%
End price
06.12.18
€18.58
Summary
This prediction ended on 06.12.18 with a price of €18.58. The BUY prediction by Quitte for Conatus Pharmaceuticals Inc. performed very badly with a performance of -60.00%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Conatus Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by Quitte for this prediction
In the thread Conatus Pharmaceuticals Inc. diskutieren
Wiedereinstieg
Conatus Pharma up 8% ahead of data readout on emricasan in NASH
Aug. 23, 2018 11:21 AM ET|About: Conatus Pharmaceuticals (CNAT)|By: Douglas W. House, SA News Editor
Micro cap Conatus Pharmaceuticals (CNAT +7.7%) is up on average volume. Shares have rallied almost 16% since touching $3.85 on August 15.
Preliminary data from a Phase 2b clinical trial evaluating emricasan in NASH should be available next quarter.
Previously: Conatus completes enrollment in mid-stage study of emricasan in NASH cirrhosis; shares ahead 1% (April 30)
(Vom Mitglied beendet)
Stopped prediction by Quitte for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.94
07.01.19
07.01.19
€27.06
08.07.19
08.07.19
-85.24%
08.07.19
08.07.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€41.40
24.01.18
24.01.18
€62.00
24.07.18
24.07.18
-13.77%
24.07.18
24.07.18
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€46.36
09.02.17
09.02.17
€65.00
09.08.17
09.08.17
-0.95%
09.08.17
09.08.17
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€46.57
06.02.17
06.02.17
€42.00
07.02.17
07.02.17
0.00%
07.02.17
07.02.17
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.74
20.10.16
20.10.16
€42.00
27.12.16
27.12.16
171.80%
27.12.16
27.12.16
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.51
05.04.16
05.04.16
€29.00
17.10.16
17.10.16
-44.10%
17.10.16
17.10.16
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.52
20.01.16
20.01.16
€16.70
09.02.16
09.02.16
2.75%
09.02.16
09.02.16
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.51
09.07.15
09.07.15
€46.00
11.01.16
11.01.16
-52.49%
11.01.16
11.01.16